NCT04312659 A Study of Infliximab in the Treatment of Chinese Children With Crohn's Disease Status COMPLETED Phase N/A
NCT04305145 Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04272788 Association of Breg and Treg With the Clinical Effects of Infliximab in the Treatment of Patients With Crohn's Disease Status COMPLETED Phase N/A
NCT04178850 Clinical Comparative Study to Evaluate the Efficacy and Safety of Recombinant Anti-TNF-alpha Antibodies for Injection Status UNKNOWN Phase PHASE3
NCT04131504 Precision Crohn's Disease Management Utilizing Predictive Protein Panels (ENvISION) Status COMPLETED Phase N/A
NCT03819296 Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer Status RECRUITING Phase PHASE1
NCT03765450 Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis Status ACTIVE_NOT_RECRUITING Phase N/A
NCT03704610 Efficacy of Remission-induction Regimen With Infliximab for Severe Extrathoracic Sarcoidosis (EFIRTES) Status COMPLETED Phase PHASE3
NCT03679546 EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis Status COMPLETED Phase PHASE4
NCT03662919 One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study Status COMPLETED Phase N/A
NCT03596645 A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03452501 Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients Status COMPLETED Phase N/A
NCT03445624 Abdominal Ultrasound With Doppler and Peripheral Hemogram in Assesment Inflammatory Bowel Disease Status COMPLETED Phase N/A
NCT03414502 Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response Status RECRUITING Phase PHASE3
NCT03371095 Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease Status COMPLETED Phase PHASE3
NCT03370601 Evaluation of the Clinical and Immunological Impact of Two Therapeutic Strategies in Chronic Inflammatory Diseases Status TERMINATED Phase NA
NCT03221166 Thalidomide Versus Infliximab in New Onset Crohn's Disease With Poor Prognostic Factors Status TERMINATED Phase PHASE3
NCT03209232 Infliximab Accelerated Induction in Moderate to Severe Pediatric UC Status TERMINATED Phase NA